Lieffering A S, Ramerman L, Hommes J E, Rakhorst H A, Mureau M A M, van der Hulst R R W J, Verheij R A
Nivel, Utrecht, the Netherlands; Tranzo, Tilburg School of Social Sciences and Behavioral Research, Tilburg University, Tilburg, the Netherlands.
Nivel, Utrecht, the Netherlands.
J Plast Reconstr Aesthet Surg. 2024 Dec;99:506-514. doi: 10.1016/j.bjps.2024.10.026. Epub 2024 Oct 18.
There has been a growing concern about a possible causal relationship between silicone breast implants (SBIs) and health symptoms, referred to as breast implant illness. This study assessed the association between SBIs for cosmetic augmentation and health symptoms.
This retrospective cohort study used the data from the Dutch Breast Implant Registry and Nivel Primary Care Database. A total of 688 women with cosmetic SBIs were age-matched with 1301 women without SBIs. The occurrence of 13 health symptoms presented in general practice was assessed 1 year before implantation until 3 years after implantation. Comparisons were made regarding the number of symptoms and general practice consultations, before and after implantation and between the two groups.
Women with SBIs were more likely to experience three or more distinct health symptoms and a combination of multiple symptoms with multiple consultations during follow-up than women without SBIs (adjusted OR 1.44, 95% CI 1.06 to 1.96; adjusted OR 1.44, 95% CI 1.04 to 2.00, respectively). Women with SBIs also had more than twice the likelihood of manifesting these outcomes in the second year after implantation compared to the first year before implantation (OR 2.13, 95% CI 1.27 to 3.57; OR 2.13, 95% CI 1.22 to 3.72, respectively).
Women with cosmetic SBIs had increased odds of developing health symptoms after implantation compared to those before implantation and to women without SBIs. These results suggest an association between health symptoms and cosmetic SBIs that needs further research to explore whether there is causality or residual confounding.
人们越来越关注硅胶乳房植入物(SBI)与健康症状之间可能存在的因果关系,即所谓的乳房植入物疾病。本研究评估了用于美容隆胸的SBI与健康症状之间的关联。
这项回顾性队列研究使用了荷兰乳房植入物登记处和Nivel初级保健数据库的数据。共有688名接受美容性SBI的女性与1301名未接受SBI的女性进行了年龄匹配。评估了在植入前1年至植入后3年期间在全科医疗中出现的13种健康症状的发生情况。比较了植入前后以及两组之间症状数量和全科医疗咨询次数。
与未接受SBI的女性相比,接受SBI的女性在随访期间更有可能经历三种或更多不同的健康症状,以及多种症状与多次咨询的组合(调整后的OR分别为1.44,95%CI为1.06至1.96;调整后的OR为1.44,95%CI为1.04至2.00)。与植入前第一年相比,接受SBI的女性在植入后第二年出现这些结果的可能性也高出两倍多(OR分别为2.13,95%CI为1.27至3.57;OR为2.13,95%CI为1.22至3.72)。
与植入前相比以及与未接受SBI的女性相比,接受美容性SBI的女性植入后出现健康症状的几率增加。这些结果表明健康症状与美容性SBI之间存在关联,需要进一步研究以探讨是否存在因果关系或残留混杂因素。